We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Next Steps After Broad Institute's Big Gene-Editing Patent Win

Law360, New York (February 16, 2017, 11:29 AM EST) -- Brian W. Nolan

Colleen Tracy James The U.S. Patent and Trademark Office’s Patent Trial and Appeal Board has been thrust into a dispute pitting University of California, Berkeley (“UC”) and the University of Vienna against the Broad Institute of MIT and Harvard (“Broad Institute”). The technology at the center of the dispute is a gene-editing tool called CRISPR-Cas9, and the PTAB’s decision could leave the winner holding a patent portfolio worth billions of dollars. In the first round of this dispute, the PTAB handed the Broad...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.